The Lustgarten Foundation is the largest private funder of the world’s preeminent pancreatic cancer researchers.
To date, we have funded more than $250 million in research grants and been a leading force in every major advancement in pancreatic cancer research.
Progress is paramount. We drive bold, innovative research with the singular mission: transforming pancreatic cancer into a curable disease.
Lustgarten Announcements
(NEW YORK) – The Cancer Research Institute (CRI) and the Lustgarten Foundation have announced a new partnership focused exclusively on supporting pancreatic cancer immunotherapy research. The partnership, INSPIRE (Integrated […]
The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a remarkable year of funding, awarding 17 new grants to researchers at 13 leading institutions. These […]
Kacper Rogala, DPhil, MRes, Stanford University School of Medicine & David Kashatus, PhD, University of Virginia School of Medicine, Awarded 2023 Innovation and Collaboration Program Grants WOODBURY, N.Y., July 24, […]
News From The Field
Elliot K. Fishman, MD, Professorship in Radiology, Professor of Radiology and Radiological Science at Johns Hopkins Medicine In this interview, he discusses how he uses artificial intelligence in his study […]
Three weeks after Geoff Shudtz’s son Emery was born, the 34-year-old first-time dad from Richmond, VA received the most crushing news imaginable: he had Stage IV pancreatic cancer. Despite undergoing […]
In May 2023, the Journal Nature published promising results from a study funded by the Pancreatic Cancer Collective (PCC), a partnership between the Lustgarten Foundation and Stand Up To Cancer. […]
SUSAN’s story
From Nurse to Patient
When Susan was diagnosed with pancreatic cancer, cutting-edge drugs and a supportive medical team helped her go from patient to survivor. Now she raises funds for continued research through a Lustgarten Foundation Walk for Research.
Read Susan’s Story
